Purchases and Sales Made in Q3 2024 in Fulcrum Therapeutics, Inc. (FULC)
This table provides information about the institutional ownership of Fulcrum Therapeutics, Inc. (FULC) during Q3 2024. The information is specifically focused on institutions that hold shares of Fulcrum Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-379K- 94.17% |
$1.21M - $3.69M
|
23.5K
$76.4K
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-428K- 24.1% |
$1.36M - $4.17M
|
1.35M
$4.38M
|
|
|
Nov 13, 2024
Q3 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-563K- 66.33% |
$1.79M - $5.49M
|
286K
$929K
|
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-884K- 71.6% |
$2.81M - $8.61M
|
351K
$1.14M
|
|
|
Nov 14, 2024
Q3 2024
|
Suvretta Capital Management, LLC
New York, NY |
SELL
|
- |
-1.36M- 53.45% |
$4.32M - $13.2M
|
1.18M
$3.84M
|
|
|
Nov 14, 2024
Q3 2024
|
Ra Capital Management, L.P.
Boston, MA |
SELL
|
- |
-1.38M- 11.89% |
$4.39M - $13.4M
|
10.2M
$33.2M
|